Scolaris Content Display Scolaris Content Display

Vitamin B for treating peripheral neuropathy

Esta versión no es la más reciente

Table 1. OVID MEDLINE STRATEGY

OVID MEDLINE

OVID MEDLINE

'mp' denotes keyword search in title,abstract,subject heading
' $' denotes truncation
'/' denotes a mesh subject heading
'Exp' denotes explosion of mesh subject heading

1. randomized controlled trial.pt.
2. randomized controlled trials/
3. controlled clinical trial.pt.
4. controlled clinical trials/
5. random allocation/
6. double‐blind method/
7. single‐blind method/
8. clinical trial.pt.
9. exp clinical trials/
10. (clin$ adj25 trial$).tw.
11. ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$ or dummy)).tw.
12. placebos/
13. placebo$.tw.
14. random$.tw.
15. research design/
16. (clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
17. multicenter study.pt.
18. meta analysis.pt.
19. Prospective Studies/
20. Intervention Studies/
21. Cross‐Over Studies/
22. Meta‐Analysis/
23. (meta?analys$ or systematic review$).tw.
24. control.tw.
25. or/1‐24
26. Animal/
27. Human/
28. 26 and 27
29. 26 not 28
30. 25 not 29
31. exp Vitamin B Complex/
32. Vitamin B.mp.
33. Aminobenzoic$.mp.
34. Biotin$.mp.
35. Folic$.mp.
36. Inosit$.mp.
37. Nicotinic$.mp.
38. Niacin$.mp.
39. Pantothenic$.mp.
40. Riboflavin$.mp.
41. Thiamin$.mp.
42. Cobamide$.mp.
43. Cobalamin$.mp.
44. Pyridox$.mp.
45. or/31‐44
46. exp Peripheral Nervous System Diseases/
47. neuropath$.mp.
48. 46 or 47
49. Pain.mp. or exp PAIN/
50. 48 and 49
51. exp Demyelinating Diseases/
52. demyelin$.mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
53. 51 or 52
54. (Guillain and Barre).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
55. (Miller and Fisher).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
56. exp LEPROSY/
57. (Leprosy or Leper$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
58. (Hansen$ and Disease).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
59. or/54‐58
60. Diabetic Neuropathies/
61. (motor and Sensory and Neuropath$ and Heredity).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
62. (Charcot and Marie).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
63. (Dejerine and Sottas).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
64. (Refsum and Syndrome$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
65. (Spastic and Parapleg$).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
66. exp "Hereditary Sensory and Autonomic Neuropathies"/
67. (Sensory and autonomic and neuropath$ and heredity).mp. [mp=title, abstract, cas registry/ec number word, mesh subject heading]
68. or/60‐67
69. 48 or 50 or 53 or 59 or 68
70. 45 and 69
71. 30 and 70

Figuras y tablas -
Table 1. OVID MEDLINE STRATEGY